Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules.
Allergan issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6×28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.
As a result of this packaging error, oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy. The reversing of the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the capsules out of order. If patients have concerns regarding the possibility of an unintended pregnancy they should consult their physician.
This product is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives. The TAYTULLA pill pack is a 28 count blister card that has 24 “active” pink softgel capsules (with hormones) with “WC” printed on the outer shell in white to be taken for 24 days, followed by 4 maroon softgel capsules (without hormones) also imprinted with “WC” on one side to be taken for the next four days. If you are a patient in the U.S. who has used a TAYTULLA sample pack from lot 5620706, Exp. May 2019 since August 27, 2017, and are concerned that you may be impacted by this issue, please consult with your physician. This product was distributed Nationwide to healthcare providers.
Please refer to the affected lot number as well as the pictures below of the affected product.
Allergan is notifying customers by recall letter and is arranging for return of all recalled sample pack product with the lot #5620706 Exp. May 2019. Consumers who have the sample pack product with the associated lot number should notify their physician to arrange a return.
Consumers with questions regarding this recall can contact Allergan by phone at 800-678-1605 8am-8pm EST Monday through Friday. Consumers should contact their physician or healthcare provider if they have questions.
For more information about TAYTULLA and the full prescribing information, please visit www.taytulla.com.
Company Contact: 1-800-678-1605
Pregnancy is a joyful time for moms-to-be, but as you decorate the nursery and plan for the baby’s arrival, don’t forget to take precautions to prevent prenatal infections. They can be dangerous for both mother and baby.
Dr. Ciaccio and Dr. Sachenko have been putting on their running shoes for several charity runs. They ran in both the “Run from the Rays 5K” and the “Music for Healing 5K” recently.
Join them in their upcoming runs!
Your vaginal health may change throughout your life, and it’s common to experience vaginal dryness at one point or another.
Hearing the news that your cancer is cured is one of the greatest and most relieving feelings! After the initial wave of happiness, however, you may have a lot of questions about what comes next.
It’s that time of year again where we all promise ourselves to make more frequent visits to the gym, eat healthier, and shed a few pounds. But how successful is this overdone New Year’s Resolution? Sure, it sounds great on paper but is it really enough motivation to get us to the gym at the crack of dawn?
You may have seen the term “BRCA 1 and BRCA 2 testing” being used on the internet in regard to breast cancer, but are you unsure about what it means? The simple explanation is this: BRCA1 and BRCA 2 are genes that help repair damaged DNA. Damaged DNA can lead to tumor growth. When either of these genes do not function properly, cells are more likely to develop genetic alterations that can lead to cancer.
We will finally be moving our Boca office to the new building in the same plaza just west of our present office.
For new moms (and even experienced ones) breastfeeding a newborn baby can be one of the most complicated and misunderstood aspects of motherhood. Many mothers and mothers-to-be have unanswered questions about breastfeeding that could help ease the process. Here are some of the most commonly asked questions, and some helpful answers, about breastfeeding for Breast Feeding Awareness Month.
40 years ago, cervical cancer was the leading cause of cancer death in American women. Since then, the number of deaths has significantly decreased due to increased awareness of the symptoms and testing methods for this disease. Although the numbers have improved, approximately 12,000 women will be diagnosed and 4,120 will die from the disease this year.